Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: Their value in early diagnosis

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 12, 2004, Pages 1000-1005

  Magliulo, Giuseppe ^a,b   Cianfrone, Giancarlo ^a,b   Gagliardi, Mario ^a,b   Cuiuli, Giuseppe ^a,b   D'Amico, Raffaello ^a,b  

^a University La Sapienza ^*  (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Distortion product otoacoustic emission; Endolymphatic hydrops; Glycerol; Vestibular evoked myogenic potential

Indexed keywords

GLYCEROL;

ADULT; ARTICLE; AUDIOLOGY; AUDIOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIZZINESS; EVOKED RESPONSE; FEMALE; HUMAN; INNER EAR; MALE; MENIERE DISEASE; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; VERTIGO; VESTIBULAR SYSTEM;

EID: 10644263484     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411301211     Document Type: Article

References (16)

1. de Waele C, Tran Ba Huy P Diard JP, Freyss G, Vidal PP. Saccular dysfunction in Meniere's disease. Am J Otol 1999;20:223-32.
2. Murofushi T, Shimizu K, Takegoshi H, Cheng PW. Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential. Arch Otolaryngol Head Neck Surg 2001;127:1069-72.
3. Harris FP, Probst R. Transiently evoked otoacoustic emissions in patients with Meniere's disease. Acta Otolaryngol (Stockh) 1992;112:36-44.
4. Kubo T, Sakashita T, Kusuki M, Nakai Y. Frequency analysis of evoked otoacoustic emissions in Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1995(suppl 519):275-81.
5. Perez N, Espinosa JM, Fernandez S, Garcia-Tapia R. Use of distortion-product otoacoustic emissions for auditory evaluation in Meniere's disease. Eur Arch Otorhinolaryngol 1997;254:329-42.
6. Sakashita T, Kubo T, Kusuki M, et al. Patterns of change in growth function of distortion product otoacoustic emissions in Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1998 (suppl 538):70-7.
7. van Huffelen WM, Mateijsen NJ, Wit HP. Classification of patients with Meniere's disease using otoacoustic emissions. Audiol Neurootol 1998;3:419-30.
8. Kusuki M, Sakashita T, Kubo T, et al. Changes in distortion product otoacoustic emissions from ears with Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1998(suppl 538):78-89.
9. Fetterman BL. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops. Laryngoscope 2001;111:946-54.
10. de Kleine E, Mateijsen DJ, Wit HP, Albers FW. Evoked otoacoustic emissions in patients with Meniere's disease. Otol Neurotol 2002;23:510-6.
11. Ohki M, Matsuzaki M, Sugasawa K, Murofushi T. Vestibular evoked myogenic potentials in patients with contralateral delayed endolymphatic hydrops. Eur Arch Otorhinolaryngol 2002;259:24-6.
12. Seo T, Yoshida K, Shibano A, Sakagami M. A possible case of saccular endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec 1999;61:215-8.
13. Murofushi T, Matsuzaki M, Takegoshi H. Glycerol affects vestibular evoked myogenic potentials in Meniere's disease. Auris Nasus Larynx 2001;28:205-8.
14. Shojaku H, Takemori S, Kobayashi K, Watanabe Y. Clinical usefulness of glycerol vestibular-evoked myogenic potentials: preliminary report. Acta Otolaryngol Suppl (Stockh) 2001 (suppl 545):65-8.
15. Sakashita T, Kubo T, Kyunai K, et al. Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 2001;104:682-93.
16. Magliulo G, Cianfrone G, Triches L, Altissimi G, D'Amico R. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops. Laryngoscope 2001;111:102-9.